SII Levels Following PENG Block in Pediatric Hip Surgery
ConditionHip Dysplasia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-8
SponsorPoznan University of Medical Sciences
About this trial
This study is a prospective, randomized, double-blind clinical trial. Its aim is to evaluate whether adding a pericapsular nerve group (PENG) block to spinal anesthesia can reduce the inflammatory response after hip surgery in children.
Hip surgery in children can cause a strong stress and inflammatory reaction, which may affect pain after surgery, the need for opioid medications, and recovery.
Children aged 3 to 8 years will be randomly assigned to one of two groups: spinal anesthesia alone or spinal anesthesia combined with a PENG block. The main goal is to compare changes in the Systemic Immune-Inflammation Index (SII), a blood-based marker of inflammation, measured before surgery and 24 hours after surgery.
Additional outcomes include other inflammatory markers, postoperative pain, opioid use, time to first rescue pain medication, and side effects.
Eligibility criteria
Qualifiers
Age 3-8 years
Scheduled for elective unilateral hip surgery
American Society of Anesthesiologists (ASA) physical status I-III
Written informed consent from the parent or legal guardian
Disqualifiers
Contraindications to spinal anesthesia or PENG block
Infection at the planned needle insertion site
Coagulation disorders
Chronic immunosuppressive therapy or chronic steroid use
Trial design
Treatments tested in this trial
- Ropivacaine 0.2% Injectable Solution
- 0.9%NaCl
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov